FI942400A0 - Lääkeaine hermosairauksia vastaan - Google Patents

Lääkeaine hermosairauksia vastaan

Info

Publication number
FI942400A0
FI942400A0 FI942400A FI942400A FI942400A0 FI 942400 A0 FI942400 A0 FI 942400A0 FI 942400 A FI942400 A FI 942400A FI 942400 A FI942400 A FI 942400A FI 942400 A0 FI942400 A0 FI 942400A0
Authority
FI
Finland
Prior art keywords
drug against
nerve diseases
against nerve
diseases
drug
Prior art date
Application number
FI942400A
Other languages
English (en)
Swedish (sv)
Other versions
FI942400A (fi
Inventor
Yasufumi Shirasaki
Hitoshi Yamaguchi
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Publication of FI942400A0 publication Critical patent/FI942400A0/fi
Publication of FI942400A publication Critical patent/FI942400A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
FI942400A 1993-05-25 1994-05-24 Lääkeaine hermosairauksia vastaan FI942400A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP12293393 1993-05-25

Publications (2)

Publication Number Publication Date
FI942400A0 true FI942400A0 (fi) 1994-05-24
FI942400A FI942400A (fi) 1994-11-26

Family

ID=14848208

Family Applications (1)

Application Number Title Priority Date Filing Date
FI942400A FI942400A (fi) 1993-05-25 1994-05-24 Lääkeaine hermosairauksia vastaan

Country Status (10)

Country Link
US (2) US5661150A (fi)
EP (1) EP0627219A1 (fi)
CN (1) CN1100301A (fi)
AU (2) AU684270B2 (fi)
CA (1) CA2124284C (fi)
FI (1) FI942400A (fi)
NO (2) NO941915L (fi)
PH (1) PH31213A (fi)
RU (1) RU2135162C1 (fi)
TW (1) TW309427B (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0792879T3 (da) * 1994-11-14 2001-03-26 Daiichi Seiyaku Co Fremgangsmåde til fremstilling af 3-[2-[4-(3-chlor-2-methylphenyl)-1-piperzinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)
CA2188816C (en) * 1996-04-23 2009-09-22 Takeda Chemical Industries, Ltd. Composition containing .alpha.-fodrin or .alpha.- fodrin fragment protein
US7202279B1 (en) 1998-02-11 2007-04-10 Georgetown University Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders
DE19820224A1 (de) * 1998-05-06 1999-12-09 Markus Schott Bindungspartner und Verfahren zur kompetitiven Hemmung der Bindung zwischen NEF-Protein und Calmodulin, sowie Mittel und Verwendung bei HIV-Erkrankungen
AU750122C (en) * 1998-06-17 2003-02-27 Bristol-Myers Squibb Company Preventing cerebral infarction through administration of ADP-receptor antiplatelet and antihypertensive drugs in combination
US6105582A (en) * 1998-07-28 2000-08-22 Pranevicius; Osvaldas Cerebral blood outflow maintenance during intracranial hypertension
EP1315971A2 (en) * 2000-07-31 2003-06-04 The Regents of The University of California Model for alzheimer's disease and other neurodegenerative diseases
GB2377635B (en) 2001-04-17 2005-10-19 Hoffmann La Roche Novel use of neuronal calcium sensor-1 (NCS-1) in therapy of CNS disorders and in the development of therapeutic agents
WO2007062862A2 (en) * 2005-12-02 2007-06-07 Ludwig Maximilians Universität München Use of calmodulin inhibitors for the treatment of neurodegenerative disorders
WO2024018245A1 (en) 2022-07-22 2024-01-25 INSERM (Institut National de la Santé et de la Recherche Médicale) Use of calpain inhibitors for the treatment of the diabetic kidney disease
WO2024153744A1 (en) 2023-01-20 2024-07-25 Institut National de la Santé et de la Recherche Médicale Autophagy activators for the treatment of rhabdomyolysis

Also Published As

Publication number Publication date
EP0627219A1 (en) 1994-12-07
AU5837298A (en) 1998-05-21
US5661150A (en) 1997-08-26
AU684270B2 (en) 1997-12-11
RU94017849A (ru) 1997-05-27
TW309427B (fi) 1997-07-01
FI942400A (fi) 1994-11-26
NO941915D0 (no) 1994-05-24
NO993627L (no) 1994-11-28
NO941915L (no) 1994-11-28
NO993627D0 (no) 1999-07-26
RU2135162C1 (ru) 1999-08-27
US5837706A (en) 1998-11-17
AU6333194A (en) 1994-12-01
PH31213A (en) 1998-05-05
CN1100301A (zh) 1995-03-22
CA2124284A1 (en) 1994-11-26
CA2124284C (en) 2002-10-01

Similar Documents

Publication Publication Date Title
FI971279A (fi) Lääkkeitä
DE69326080D1 (de) Implantierbare elektrode
NO942923L (no) Medikamenter
NO953838D0 (no) Fjernbart medisinsk elektrodesystem
DE69317246D1 (de) Physiologisch angepasster frequenzadaptiver Zweikammer-Herzschrittmacher
DE69510024D1 (de) Spritze
BR9304747A (pt) Injetor de medicamentos
FI931234A0 (fi) Foerfarande foer oevervakning av en patients tillstaond
BR9600809A (pt) Medicamento
FI942400A0 (fi) Lääkeaine hermosairauksia vastaan
BR9508339A (pt) Medicamento
DE69618560D1 (de) Medikament gegen ophthalmische erkrankungen
FI955605A0 (fi) Aryloivia lääkkeitä
DE59602953D1 (de) Fungizide wirkstoffkombinationen
DE59602890D1 (de) Fungizide wirkstoffkombinationen
DE59610423D1 (de) Partikulare arzneiform
IT230757Y1 (it) Cannula per fleboipodermoclisi
KR950032276U (ko) 의약품 투여용 피부 흠집 형성구
ITMI922518A0 (it) Medicazione per patologie cutanee
NO933315D0 (no) Legemiddel
IT230756Y1 (it) Cannula per fleboipodermoclisi
SE9401674L (sv) Läkemedel
SE9402131D0 (sv) Läkemedel
NO944330D0 (no) Legemiddel
TH13625EX (th) เอเซียโลไกลโคโปรตีน-ตัวยาคอนจูเกท